Status of the VEGF expression in Indian gastric cancer patients.
Abstract
Department of Surgical Gastroenterology and Proctology,
MADRAS MEDICAL COLLEGE AND GOVERNMENT GENERAL HOSPITAL
Full Text:
PDFReferences
Ferlay J, Shin HR, Bray F, Forman
D, Mathers C, Parkin DM. Peter
Boyle, Bernard Levin. GLOBOCAN
, Cancer Incidence and
Mortality Worldwide: IARC Cancer-
Base No. 10. Lyon, France: International
Agency for Research on Cancer.
Available from: http: //
www.globocan.iarc.fr. World Cancer
Report, 2008 IARC; 2008 .
Mohandas KM, Jagannath P.
Epidemiology of digestive tract
cancers in India. VI. Projected burden
in the new millennium and the
need for primary prevention. Indian
J Gastroenterol. 2000;19:748.
Correa P, Haenszel W, Cuello C,
Tannenbaum S, Archer M: A model
of gastric cancer epidemiology.
Lancet 1975, 2 (7924): 58-60.26.
Gao L, Nieters A, Brenner H: Metaanalysis:
tumorinvasionrelated genetic
polymorphisms and gastric
cancer susceptibility. Aliment PharmacolTher
, 28 (5): 565-573.
Folkman J : How is blood vessel
growth regulated in normal and
neoplastic tissue? G.H.A. Clowes-
Memorial Award Lecture. Cancer
Res 46: 467-473, 1986.
Tanigawa N, Amaya H, Matsumura
M and Shimomatsuya T: Association
of tumor vasculature withtumor
progression and overall survival
of patients with non-early gastric
carcinomas. Br J Cancer 75:
-571, 1997.
Folkman J. In: DeVita VT Jr, Hellman
S, Rosenberg SA, Eds. Cancer: Principles
& Practice of Oncology. Vol 2. 7th
Ed. Philadelphia, PA: Lippincott Williams
& Wilkins; 2005:2865-2882.
Hanrahan V, Currie MJ, Gunningham
SP, et al. The angiogenic switch for vascular
endothelial growth factor (VEGF) -
A, VEGF-B, VEGF-C, and VEGF-D in the
adenoma-carcinoma sequence during
colorectal cancer progression J
Pathol. 2003;200:183-194.
Tannock IF, Hill RP, Bristow RG, et al,
Eds. Basic Science of Oncology. 4th Ed.
New York, NY: McGraw-Hill; 2005:231-
Fontanini G, Vignati S, Boldrini L, et al.
Vascular endothelial growth factor is associated
with neovascularization and influences
the progression of non-small cell
lung carcinoma. Clin Cancer
Res. 1997;3:861-865.
MAEDA K., CHUNG Y., OGAWA Y.,
TAKATSUKA S., KANG S. M.,
OGAWA M., SAWADA T., SOWA M., Pro
g n o s t i c v a l u e o f v a s -
clar endothelial growth factor expression i
n gastriccarcinoma, Cancer, 1996, 77
(5):858–863.
IKEGUCHIM.,
OKAS.,SAITOH.,KONDOA.,TSUJI
TANIS.MAETAM.,KAIBARAN.,Theexpres
sion of thymidine phosphorylase
and its correlation with angiogenesis
in gastric
adenocarcinoma, Anticancer Res, 19
, 19(5B):4001–4005.
GAO Z. L., ZHANG C., DU G. Y.,
LU Z. J., Clinical significance
of changes in tumor markers,
extracellular matrix MMP-9
and VEGF in p a t i e n t s
with gastric carcinoma,Hepatogastro
enterology, 2007, 54(77):1591–1595.
BOKU N., OHTSU A., NAGASHIMA
F., SHIRAO K., KOIZUMI W.
Relationship between expression of
vascular endothelial growth factor in
tumor tissue from gastric cancers and
chemotherapy effects: comparison
between S-1 alone and the combination
of S-1 plus CDDP, Jpn J ClinOncol,
, 37 (7): 509–514.
WANG G., DONG Z., XU G.,
YANG Z., SHOU C., WANG N., LIU
T., The effect of antibody against vascular
endothelial growth factor on tumor
growth and metastasis, J Cancer
Res ClinOncol, 1998, 124 (11): 615–
ISHIKAWA M., KITAYAMA J., KAZAMA
S., NAGAWA H., Expression of
vascular endothelial growth factor
(VEGF) -Cain proprietary specimens
and metastatic foci of regional lymph
nodes in submucosal gastric carcinoma,
World JSurgOncol, 2005, 3 (1):
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr MGR Medical University